Source: PR-Inside

Press Release: Mercator MedSystems : Mercator MedSystems Announces Receipt of NIH Grant for Research and ...

(PR-inside.com) EMERYVILLE, CA / ACCESSWIRE / January 10, 2022 / Mercator MedSystems, Inc. ("Mercator" or the "company"), announced today that research has begun under a small business technology transfer (STTR) grant for approximately $300,000 funded by the National Institutes of Health (NIH). Preclinical research performed using the grant resources is intended to demonstrate mechanistic effects of local delivery of anti-inflammatory drugs to treat deep vein thrombosis (DVT). DVT occurs when large veins deep in the leg and pelvic region become inflamed due to injury, stagnation of blood flow, and factors in the blood that increase the likelihood for coagulation to occur. Kirk Seward, PhD, President and Chief Science ..

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Trent Reutiman's photo - CEO of Mercator MedSystems

CEO

Trent Reutiman

CEO Approval Rating

94/100

Read more